The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth $8,622.72 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. This contract is for the delivery of 120 capsules of the drug Xtandi (40 mg) to support the medical supply needs of military health facilities. The contract has an ultimate completion date of December 12, 2024.
DMS Pharmaceutical Group Inc. holds a larger single-award Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, valued at $499,999,999 and valid through November 2026. This IDC enables the DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical items, including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables, to support the medical supply needs of Department of Defense healthcare sites worldwide. The contract does not have a set-aside designation, allowing DMS Pharmaceutical Group Inc. to leverage its status as a woman-owned small business to secure direct federal awards across multiple product categories and medical domains.
Generated 3/12/25, 9:43 AM